- Home
- REXR vs SNN Comparison
REXR vs SNN Comparison
Compare REXR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REXR | SNN |
|---|---|---|
| Founded | 2013 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REXR | SNN |
|---|---|---|
| Price | $32.63 | $31.65 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $41.00 | $36.25 |
| AVG Volume (30 Days) | ★ 2.4M | 778.5K |
| Earning Date | 04-23-2026 | 03-02-2026 |
| Dividend Yield | ★ 5.33% | 2.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.98 | $7.19 |
| Revenue Next Year | $3.36 | $5.36 |
| P/E Ratio | ★ $43.28 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.68 | $23.91 |
| 52 Week High | $44.38 | $38.79 |
Technical Indicators
Market Signals| Indicator | REXR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 26.20 | 33.01 |
| Support Level | N/A | $29.27 |
| Resistance Level | $37.69 | $31.63 |
| Average True Range (ATR) | 0.75 | 0.45 |
| MACD | -0.12 | -0.12 |
| Stochastic Oscillator | 2.02 | 3.76 |
Price Performance
Historical ComparisonAbout REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.